title: Risk factors of acute renal failure after liver transplantation.
abstract: The objective of this study was to determine the risk factors of postoperative acute renal failure (ARF) in orthotopic liver transplantation (OLT). We reviewed 184 consecutive OLT. Postoperative ARF was defined as a persistent rise of 50% increase or more of the S-creatinine (S-Cr). The patients were classified as early postoperative ARF (E-ARF) (first week) and late postoperative ARF (L-ARF) (second to fourth week). Preoperative variables were age, sex, comorbidity, indication for OLT, Child-Pugh stage, united network for organ sharing status, analysis of the blood and urine, and donor's data. Intraoperative variables were systolic arterial pressure, mean arterial pressure, pulmonary capillary wedge pressure, cardiac index, and systemic vascular resistance index. Surgical technique, number of blood products transfused, need for adrenergic agonist drugs, and intraoperative complications were also important. Postoperative variables were duration of stay in the intensive care unit, time on mechanic ventilation, liver graft dysfunction, need for adrenergic agonist drugs, units of blood products infused, episodes of acute rejection, re-operations, and bacterial infections. Firstly we carried out a univariate statistical analysis, and secondly a logistic regression analysis. The risk factors for E-ARF were: pretransplant ARF (odds ratio (OR)=10.2, P=0.025), S-albumin (OR=0.3, P=0.001), duration of treatment with dopamine (OR=1.6, P=0.001), and grade II-IV dysfunction of the liver graft (OR=5.6, P=0.002). The risk factors for L-ARF were: re-operation (OR=3.1, P=0.013) and bacterial infection (OR=2.9, P=0.017). The development of E-ARF is influenced by preoperative factors such as ARF and hypoalbuminemia, as well as postoperative factors such as liver dysfunction and prolonged treatment with dopamine. The predicting factors of L-ARF differ from E-ARF and correspond to postoperative causes such as bacterial infection and surgical re-operation.
authors.affiliation: Nephrology Unit, Santa María del Rosell Hospital, Cartagena, Spain.
authors.forename: J B
authors.initials: JB
authors.lastname: Cabezuelo
authors.forename: P
authors.initials: P
authors.lastname: Ramírez
authors.forename: A
authors.initials: A
authors.lastname: Ríos
authors.forename: F
authors.initials: F
authors.lastname: Acosta
authors.forename: D
authors.initials: D
authors.lastname: Torres
authors.forename: T
authors.initials: T
authors.lastname: Sansano
authors.forename: J A
authors.initials: JA
authors.lastname: Pons
authors.forename: M
authors.initials: M
authors.lastname: Bru
authors.forename: M
authors.initials: M
authors.lastname: Montoya
authors.forename: F S
authors.initials: FS
authors.lastname: Bueno
authors.forename: R
authors.initials: R
authors.lastname: Robles
authors.forename: P
authors.initials: P
authors.lastname: Parrilla
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology* / Q000503:physiopathology / Q000652:urine; D000328:Adult; D000418:Albumins / Q000032:analysis; D001424:Bacterial Infections / Q000209:etiology; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003404:Creatinine / Q000652:urine; D004298:Dopamine / Q000627:therapeutic use; D005260:Female; D006085:Graft Survival; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008099:Liver / Q000503:physiopathology; D016031:Liver Transplantation / Q000009:adverse effects* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D011183:Postoperative Complications / Q000209:etiology / Q000382:microbiology; D011379:Prognosis; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000418:Albumins; D002316:Cardiotonic Agents; D003404:Creatinine; D004298:Dopamine